Peiyuan Bai

937 total citations · 1 hit paper
13 papers, 510 citations indexed

About

Peiyuan Bai is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peiyuan Bai has authored 13 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peiyuan Bai's work include Cardiac Fibrosis and Remodeling (5 papers), Signaling Pathways in Disease (4 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Peiyuan Bai is often cited by papers focused on Cardiac Fibrosis and Remodeling (5 papers), Signaling Pathways in Disease (4 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Peiyuan Bai collaborates with scholars based in China, United States and Japan. Peiyuan Bai's co-authors include Daile Jia, Junbo Ge, Aijun Sun, Siqin Chen, Jin Liu, Xinyu Weng, Wenlong Yang, Kai Hu, Zeng Wang and Jian Wu and has published in prestigious journals such as Circulation, Nature Communications and Circulation Research.

In The Last Decade

Peiyuan Bai

13 papers receiving 508 citations

Hit Papers

Cardiac Resident Macrophage-Derived Legumain Improves Car... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peiyuan Bai China 9 231 183 138 109 82 13 510
Silvia González-Ramos Spain 16 253 1.1× 160 0.9× 209 1.5× 66 0.6× 66 0.8× 21 597
Xinyang Hu China 11 260 1.1× 99 0.5× 90 0.7× 64 0.6× 105 1.3× 34 564
Tan Pham United States 11 252 1.1× 222 1.2× 132 1.0× 122 1.1× 111 1.4× 18 645
Shuaibo Huang United States 10 292 1.3× 330 1.8× 109 0.8× 49 0.4× 150 1.8× 14 617
Naveen K Somanna United States 10 211 0.9× 205 1.1× 69 0.5× 41 0.4× 55 0.7× 14 454
Dippal Parikh United States 9 159 0.7× 110 0.6× 128 0.9× 109 1.0× 103 1.3× 11 447
Ruoshui Li China 13 187 0.8× 157 0.9× 71 0.5× 44 0.4× 62 0.8× 23 397
Ivana Zlatanova France 11 324 1.4× 226 1.2× 196 1.4× 36 0.3× 123 1.5× 12 622
Maria T. K. Zaldivia Australia 9 237 1.0× 133 0.7× 78 0.6× 72 0.7× 60 0.7× 12 566

Countries citing papers authored by Peiyuan Bai

Since Specialization
Citations

This map shows the geographic impact of Peiyuan Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiyuan Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiyuan Bai more than expected).

Fields of papers citing papers by Peiyuan Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiyuan Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiyuan Bai. The network helps show where Peiyuan Bai may publish in the future.

Co-authorship network of co-authors of Peiyuan Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Peiyuan Bai. A scholar is included among the top collaborators of Peiyuan Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiyuan Bai. Peiyuan Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Liu, Ao, Peiyuan Bai, Lu Tang, et al.. (2025). SLAMF7 Restrains Pro-Inflammatory Macrophage Activation to Counteract Doxorubicin-Induced Cardiotoxicity. JACC Basic to Translational Science. 10(8). 101256–101256. 3 indexed citations
2.
Zhuang, Ze‐Hao, Ao Liu, Lu Tang, et al.. (2024). Hyperuricemia suppresses lumican, exacerbating adverse remodeling after myocardial infarction by promoting fibroblast phenotype transition. Journal of Translational Medicine. 22(1). 983–983. 2 indexed citations
3.
Bai, Peiyuan, et al.. (2023). ESCRT-III Component CHMP4C Attenuates Cardiac Hypertrophy by Targeting the Endo-Lysosomal Degradation of EGFR. Hypertension. 80(12). 2674–2686. 5 indexed citations
4.
Bai, Peiyuan, Siqin Chen, Daile Jia, et al.. (2022). Environmental eustress improves postinfarction cardiac repair via enhancing cardiac macrophage survival. Science Advances. 8(17). eabm3436–eabm3436. 32 indexed citations
5.
Li, Xiaoming, Peiyuan Bai, Ming Li, et al.. (2022). Caspase-8 Promotes Pulmonary Hypertension by Activating Macrophage-Associated Inflammation and IL-1β (Interleukin 1β) Production. Arteriosclerosis Thrombosis and Vascular Biology. 42(5). 613–631. 42 indexed citations
6.
Liu, Jin, Lihong Pan, Wenxuan Hong, et al.. (2022). GPR174 knockdown enhances blood flow recovery in hindlimb ischemia mice model by upregulating AREG expression. Nature Communications. 13(1). 7519–7519. 27 indexed citations
7.
Jia, Daile, Siqin Chen, Peiyuan Bai, et al.. (2022). Cardiac Resident Macrophage-Derived Legumain Improves Cardiac Repair by Promoting Clearance and Degradation of Apoptotic Cardiomyocytes After Myocardial Infarction. Circulation. 145(20). 1542–1556. 149 indexed citations breakdown →
8.
Jia, Daile, et al.. (2021). Tregs-derived interleukin 35 attenuates endothelial proliferation through STAT1 in pulmonary hypertension. Annals of Translational Medicine. 9(11). 926–926. 8 indexed citations
9.
Kong, Deping, Qiangyou Wan, Juanjuan Li, et al.. (2020). DP1 Activation Reverses Age-Related Hypertension Via NEDD4L-Mediated T-Bet Degradation in T Cells. Circulation. 141(8). 655–666. 30 indexed citations
10.
Jia, Daile, Peiyuan Bai, Jiao Liu, et al.. (2020). Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages. Circulation Research. 127(10). 1323–1336. 37 indexed citations
11.
Bai, Peiyuan, Tingting Yu, Caojian Zuo, et al.. (2019). Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-β1 Signaling. Arteriosclerosis Thrombosis and Vascular Biology. 39(4). e130–e145. 58 indexed citations
12.
Fu, Jie, et al.. (2019). Inhibition of miR-495 Improves Both Vascular Remodeling and Angiogenesis in Pulmonary Hypertension. Journal of Vascular Research. 56(2). 97–106. 13 indexed citations
13.
Jia, Daile, Hao Jiang, Xinyu Weng, et al.. (2019). Interleukin-35 Promotes Macrophage Survival and Improves Wound Healing After Myocardial Infarction in Mice. Circulation Research. 124(9). 1323–1336. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026